BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.5% | 40.5% | 100.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 86% | 84.2% | 80.6% | 71.6% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 26.7% | 25.9% | 11.3% | -31.9% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 50.9% | 16.4% | -13.7% | -60.9% |
| EPS Diluted | 0.82 | 0.24 | -0.18 | -0.54 |
| % Growth | 241.7% | 233.3% | 66.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |